Pfizer finds generics partner for China; Obama targets opioid abuse;

> Pfizer and Chinese drugmaker Zhejiang Hisun Pharmaceuticals are partnering on the manufacturing and marketing of branded generics in China. Story

> The White House is targeting extended-release opioids in a campaign to reduce abuse and misuse of prescription drugs. Story

> Global Health Ventures has tapped Canadian CMO Confab for production of clinical supplies of X-Excite, a candidate treatment for sexual enhancement. Article

> Taro Pharmaceuticals Canada is recalling Docusate sodium capsules from the Canadian market due to possibility of contamination with the bacterial organism cronobacter (enterobacter) sakazakii. Item

> Elite Pharmaceuticals will provide lab stability studies, manufacturing and packaging for two generic products under a supply pact with Mikah Pharma. Report

> Manufacturing remediation charges from its U.S.-unit Caraco continue to be a drag on operating profit margin at Sun Pharma. Article

> A $1,000 investment in fake drugs can return $30,000, 10 times the typical profit from the same investment in heroin. News

> Startup CertiRx has developed technology to embed a tiny tags made of excipients into drugs, allowing for identification and authentication. Story

> French vaccine maker Sanofi Pasteur has relieved the founder and managing director of its Indian subsidiary, Shantha Biotech, of executive responsibilities following the collapse of a promising vaccine. Item

> BioVigilant Systems has unveiled a rapid biologic detection system for real-time environmental air monitoring in pharma manufacturing environments. Article